BILTRICIDE® (Praziquantel 600mg) Discontinuation in Australia – Special Access Scheme Options Available

Bayer Australia Ltd has announced that BILTRICIDE® (Praziquantel 600mg Tablet bottle, AUST R: 18845) will be discontinued in Australia from March 31, 2025 due to manufacturing reasons. Until then, supply will be limited and tightly controlled, with availability reducing as stock is exhausted.

For patients requiring praziquantel treatment, it is crucial to speak with a healthcare professional as soon as possible to discuss ongoing treatment options.

At Pro Pharmaceuticals Group, we understand the impact of essential medicines being discontinued. With the Biltricide discontinuation in Australia, we may be able to assist through the TGA Special Access Scheme (SAS), providing access to suitable alternatives where clinically appropriate.

For more information on availability and how we can assist, please contact us directly at orders@propg.com.au or visit our website at www.propg.com.au.